NASDAQ:ARCT | Free Cash Flow | Arcturus Therapeutics Holdings Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2018-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$19.44M$0.00-$19.44M
2025-12-31-$16.23M-$88,000.00-$16.32M
2025-03-31-$35.14M$137,000.00-$35.28M
2024-12-31-$284,000.00$0.00-$284,000.00
2024-03-31-$5.56M$240,000.00-$5.8M
2023-12-31-$629,000.00$875,000.00-$1.5M
2023-03-31-$35.87M$691,000.00-$36.56M-72.04%
2022-12-31$160.26M$3.81M$156.45M133.32%
2022-03-31-$49.04M$2.11M-$51.15M
2021-12-31-$42.5M$1.12M-$43.62M
2021-03-31-$42.95M$118,000.00-$43.07M
2020-12-31-$6.63M$697,000.00-$7.33M
2020-03-31-$11.86M$142,000.00-$12M
2019-12-31-$7.54M$315,000.00-$7.85M
2019-03-31-$5.41M$78,000.00-$5.49M
2018-12-31-$5.76M$225,000.00-$5.99M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$74.27M$230,000.00-$74.5M
2024-12-31-$59.75M$648,000.00-$60.4M
2023-12-31-$18.1M$2.9M-$21M
2022-12-31$31.99M$7.73M$24.27M259.57%
2021-12-31-$135.04M$3.41M-$138.45M
2020-12-31-$42.86M$1.74M-$44.6M
2019-12-31-$6.45M$818,000.00-$7.26M
2018-12-31-$20.76M$1.48M-$22.24M